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Summary 
To determine whether the human thymus provides an environment for the maturation of murine 
T  cells, human fetal thymus and liver (hu-thy/liv) were implanted into congenitally athymic 
NIH-beige-nude.xid (BNX) mice or C.B-17 scid/scid  (SCID) mice.  3 mo after implantation, 
in contrast to the hu-thy/liv implant in SCID mice, which was populated only with human 
CD4/CD8 single- and double-positive thymocytes, the hu-thy/liv implant in BNX mice contained 
a chimeric population of human and mouse CD4/CD8 single- and double-positive thymocytes. 
Immunohistochemical  staining of the hu-thy/liv implant in BNX mice indicated that the population 
of double-positive mouse thymocytes was localized to discrete areas of the human fetal thymus. 
Quantitative improvements in mouse T cell and immunoglobulin (Ig)G parameters were observed 
after grafting of the human fetal thymus and liver tissue into BNX mice. In addition, in contrast 
to the nonimplanted BNX mice, the implanted BNX mice were capable of mounting a keyhole 
limpet hemocyanin-specific IgG response and thdr peripheral T cells were responsive to stimulation 
with mitogens and antibodies directed to the T cell receptor. Furthermore, after in vivo priming, 
T cells present in lymph nodes of the implanted BNX mice were capable of mounting an antigen- 
induced in vitro T cell-dependent proliferative response. Thus, concurrent with the continued 
maturation of human T cells, murine T cells differentiated within the human fetal thymus implanted 
in the BNX mice and mediated the phenotypic and functional reconstitution of the murine immune 
system. Mice with a reconstituted immune system that contain a human thymic implant that 
is infectible with human immunodeficiency  virus (HIV) should prove useful in the investigation 
of T  cell maturation in the thymus and in the evaluation  of potential HIV vaccines. 
T 
he reduced ability of NIH-beige-nude-xid (BNX) 1 mice 
and C.B-17 scid/scid (SCID) mice to mount an effective 
cellular and humoral immune response limits their capacity 
to reject xenografts and therefore permits them to be suc- 
cessfully engrafted with human hematolymphoid cells (1). 
The etiology of the congenital immunodefidency of BNX 
mice differs from that of SCID mice. The BNX strain was 
derived by crossing congenitally athymic nude mice with NK 
cell-deficient beige mice and LAK cell-deficient xid mice (2). 
BNX mice also have a severe Ig deficiency due to the com- 
bined effect of a marked decrease in the numbers of helper 
T  cells and in the subset of T cell-independent B cells (1). 
Since other components of the immune system besides T cells 
1 Abbreviations used in this paper: BNX, NIH-beige-nude-xid;  hu-thy/liv, 
human fetal thymus and liver. 
play a role in xenograft rejection (3), the BNX mice are more 
tolerant for xenografts than the parental nude mice (1, 4). 
In contrast to the etiology of the T cell defect in BNX mice, 
the cause of the T cell defect in SCID mice is not the absence 
of a functional thymus but rather impaired maturation of 
T  cells secondary to the defective recombination of the an- 
tigen receptor genes (5, 6). Therefore, while the immuno- 
deficiency of congenitally athymic mice can be restored by 
the implantation of either allogeneic mouse thymus (7-10) 
or xenogeneic rat thymic tissue (11), the intrinsic cellular im- 
mune defect of SCID mice is not corrected by thymic trans- 
plantation (12). 
To investigate whether human thymus could provide an 
environment wherein mouse and human T cells could con- 
currently mature, human fetal thymus and liver (hu-thy/liv) 
were implanted in BNX mice.  We postulated that mouse 
T cells that matured in the human thymic environment would 
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mice reconstituted with rat thymic tissue (11).  In addition, 
continued maturation of human thymocytes should ensue if 
fetal liver were coimplanted with the human fetal thymus 
as described for SCID mice (13). Since the capacity of T cells 
to distinguish  between  self and  nonself is acquired in the 
thymus and involves positive and negative selection (14-16), 
a thymic environment wherein two xenogeneic T cell lineages 
were maturing should provide a unique model for the study 
of intrathymic differentiation. We report that after implan- 
tation of hu-thy/liv into BNX mice, murine thymocytes ma- 
tured within the hu-thy/liv graft and mediated the pheno- 
typic and functional reconstitution of the murine immune 
system concurrent with the continued growth and matura- 
tion of human  thymocytes. 
Materials  and  Methods 
Animals.  A colony of SCID mice was established from founder 
C.B-17 scid/scid mice delivered by Caesarean section (Taconic Farms, 
Germantown, NY) and was maintained in pathogen-free sterile 
isolators (Standard Safety, Palatine,  IL) without prophylactic an- 
tibiotic treatment at the Albert Einstein College of Medicine An- 
imal Institute. Homozygous BNX (bg/bg-nu/nu-x~/x ~) mice were 
obtained from the National Cancer Institute (Frederick, MD) and 
were maintained in microisolator cages. Control C.B-17 mice were 
acquired from Taconic Farms.  All of the mice were cared for ac- 
cording to institutional guidelines, and all food, water, caging, and 
bedding were autodaved before use. 
Implantation of hu-thy/liv  Tissue Into SCID or BNX Mice.  The 
consent forms and procedures used in this study were reviewed and 
approved by the Albert Einstein College of Medicine Committee 
on Clinical Investigation. After the elective termination of preg- 
nancy,  hu-thy/liv  tissue  obtained  from  17-21-gestational-week 
fetuses were implanted into male (6-8-wk-old) mice within 8 h 
of availability. The fetal gestational age was determined by foot 
length measurements as described (17). After the SCID or BNX 
mice were anesthetized with pentobarbital (40-80 mg/kg), a 3-cm 
incision was made in the left flank, the left kidney was exterio- 
rized, and l-ram  3 pieces of hu-thy/liv were implanted with a 16- 
gauge trocar under the kidney capsule as described (18). The peri- 
toneal layers were approximated with 7-0 nylon sutures and the 
wound was closed with an Autoclip (Clay Adams, Parsippany, NJ). 
AU surgical procedures were performed in a laminar flow hood using 
sterile technique. After surgery, the mice were started on trimeth- 
oprim/sulfamethoxazole antibiotic (TMS; Schein Pharmaceutical 
Inc., Port Washington, NY) prophylaxis as described (19) and were 
housed in bonnetted isolator cages (Lab Products Inc., Federals- 
burg,  MD)  in  an  environment  that  was  monitored for mouse 
pathogens. 
Recovery of Tissue and Cells  from Mice.  Blood was obtained from 
the retro-orbital sinus of anesthetized mice at the indicated times, 
and serum was obtained or peripheral leukocytes were isolated as 
described (20). Selected mice were killed by lethal ether inhalation 
and the hu-thy/liv implants,  spleens, and lymph nodes were re- 
moved, dissected free of connective tissue, and divided. A portion 
of the tissues was immediately embedded in OCT, snap frozen in 
liquid nitrogen, and stored at  -70~  for immunohistochemical 
analysis. Single cell suspensions  were obtained from another por- 
tion of the tissues by gently teasing it apart, and then filtering the 
suspension  through a sterile stainless steel mesh. After lysis of red 
blood cells by incubation in Tris-buffered ammonium chloride, the 
cells were washed three times in ice-cold PBS containing 1% BSA 
and 0.01% NaN3 wash buffer, and then resuspended for flow cyto- 
metric analysis. 
Antibodies.  For flow cytometric analysis, cells were stained with 
PE-conjugated mouse mAb to human CD4 (Leu 3a; Becton Dick- 
inson & Co., Mountain View, CA), FITC-conjugated mouse mAb 
to human CD8 (Leu 2a; Becton Dickinson & Co.), PE-conjugated 
rat mAb  to mouse CD4  (Pharmingen,  San Francisco,  CA),  or 
FITC-conjugated rat mAb to mouse CD8 (Pharmingen). For im- 
munohistochemical staining,  sections were either incubated with 
biotin-conjugated mouse mAb to human CD45 (Pharmingen), or 
incubated first with rat mAb to mouse CD4 (Boehringer Mann- 
heim Biochemicals,  Indianapolis,  IN) or rat mAb to mouse CD8 
(Boehringer Mannheim Biochemicals),  and then incubated with 
biotinylated rabbit antibodies (mouse adsorbed) to rat IgG (Vector 
Laboratories,  Burlingame,  CA).  For ELISAs,  alkaline  phospha- 
tase-conjugated goat (human adsorbed)  antibody to mouse IgG, 
goat (mouse adsorbed) antibody to human IgG, and alkaline phos- 
phatase-conjugated goat (mouse adsorbed) antibody to human IgG 
were obtained from Jackson Immunolabs (West Grove, PA). For 
stimulation of mouse T cells, hamster antibody directed specifically 
against  the CD3e component of the mouse TCK-CD3 complex 
was obtained from Boehringer Mannheim Biochemicals.  All the 
antibodies used were species specific and noncrossreactive as deter- 
mined by performing the appropriate control experiments. 
Flow Cytometric Analysis.  The surface expression of mouse CD4 
and CD8 or human CD4 and CD8 by lymphocytes was determined 
by two-color flow cytometric analysis. Briefly, single cell suspen- 
sions (5  x  104 cells) were incubated with the indicated  antibodies 
for 30 min at 4~  washed in wash buffer, fixed in 1% parafor- 
maldehyde in PBS for 12 h, and then washed and resuspended in 
wash buffer. The indicated cell population was analyzed using a 
FACScan  |  cell analyzer with Lysis-lI software (Becton Dickinson 
& Co.). After nonviable cells and unlysed red blood cells were gated 
out based on their forward and side scatter profiles, 20,000 events 
per sample were acquired.  Lymphocyte gates were set on the basis 
of forward and side scatter profiles to correspond to gates set to 
include both control human (from healthy adult volunteer) and 
mouse (from healthy C.B-17 mice) lymphocytes. After compensa- 
tion for PE vs. FITC emission based on the analysis of single and 
double staining of positive and negative control samples (human 
adult and C.B-17 mouse mononuclear cells) and analysis of the ap- 
propriate isotype controls, cut off  values for the quadrants were set. 
Mitogen  Stimulation  Assays.  Mouse spleen  mononuclear cells 
were isolated  by centrifugation over a Ficoll-Hypaque gradient, 
washed, suspended in RPMI 1640 with added 10% heat-inactivated 
FCS and 2-ME (50 gM), plated (2.5  x  10  s cells/well)  in 96-well 
round-bottomed microplates,  and cultured at 37~  for 3 d. Cells 
in quadruplicate wells  were stimulated with either PHA  (0.25 
gg/well) or Con A (0.5/~g/well). Cellular proliferation was as- 
sessed  by  determining  the  incorporation  of [3H]thymidine  (1 
gCi/well) added during the last 6 h of culture as described  (21). 
T Cell Stimulation Assay.  The responsiveness ofT cells present 
in the mice to stimulation with an antibody directed against  the 
CD3e component of the mouse TCR-CD3 complex was assessed 
as described (22, 23). Indicated wells of flat-bottomed microplates 
were coated with hamster anti-mouse CD3e (2.5 gg/well) in 50 
gl of PBS for 1 h  at 37~  and unbound antibody was washed 
away. Sphnocytes (2  x  10S/well) were cultured in anti-mouse 
CD3e-coated or uncoated wells in RPMI 1640 with added 10% 
heat-inactivated FCS, 2-ME (50 #M), and I ng/ml PMA (Sigma 
Chemical Co., St. Louis, MO) for 72 h. Cellular proliferation was 
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#Ci/well) added during the last  24 h of culture. 
Immunohistochemistry.  Serial frozen sections (5 #m) of the hu- 
thy/liv implants were mounted on slides coated with poly-t.-lysine 
(Sigma Chemical Co.) and then fixed in cold acetone at 4~  for 
10 min. The sections were incubated overnight at 4~  with either 
biotin-conjugated mouse mAb to human CD45, rat mAb to mouse 
CD4, or rat mAb to mouse CD8. Sections to which primary rat 
mAbs had been applied were incubated with biotinylated rabbit 
antibodies to rat IgG for 30 min.  The sections were stained  by 
the avidin-biotin-peroxidase complex (ABC) method using an ABC 
kit (Vector Laboratories), and bound antibodies were visualized using 
the substrate diaminobenzadine (Sigma Chemical Co.). The sec- 
tions were washed twice with Tris-buffered saline (pH 7.4) between 
each step. 
Quantitation of Mouse IgG Subclass Antibody Levels.  The con- 
centrations of mouse IgG1, IgG2a, IgG2b, and IgG3 antibodies 
present in serum were measured by using IgG subclass-specific  radial 
immunodiffusion (RID) plates (Tago Inc., Burlingame, CA). An 
aliquot of appropriately diluted serum was applied to wells in the 
RID plates, incubated for 24 h at 37~  and then the concentra- 
tions of the IgG subclass antibodies were determined according 
to the manufacturer's protocol. Crossreactivity with human anti- 
bodies was not observed, and proper assay conditions were ensured 
by the inclusion of internal standards  on every plate. 
Measurement of Human IgG Antibody Levels.  The serum con- 
centration of human IgG in the BNX-hu and SCID-hu mice was 
measured by a human IgG-specific  ELISA using a variation of a 
previously  described  technique  (21).  Briefly,  microtiter  plates 
(Coming, Coming, NY) were coated for 1 h at 37~  with goat 
anti-human IgG diluted 1:2,000 in 100 mM NaHCO3 (pH 9.6) 
and then washed.  After incubation of the appropriately diluted 
serum samples in duplicate for 1 h at 37~  the wells were washed, 
and alkaline  phosphatase-conjugated goat anti-human  IgG was 
added for 1 h at 37~  The plates were washed, substrate solution 
(p-nitrophenyl phosphate; Sigma Chemical Co.) was added, and 
absorbance at  405 nm was  measured with  an  automated spec- 
trophotometer  (Titertek  Multiscan;  Flow  Laboratories,  Inc., 
McLean, VA). Human IgG standards were run simultaneously with 
the serum samples to generate a standard curve, and the IgG con- 
centration of the samples was calculated by a computer program 
(Titersoft; Flow Laboratories,  Inc.). Crossreactivity of the ELISA 
with mouse Ig was not observed. 
Detection of Anti-KLH-specific IgG.  BNX-hu  mice and age- 
matched BNX mice were immunized by intraperitoneal injection 
with 100 #g of KLH (Pierce Chemical Co., Rockford, IL) emulsified 
in CFA (Difco Laboratories,  Detroit, MI) and boosted I mo later 
with 100 #g of KLH emulsified in IFA as described (24, 25). Anti- 
KLH mouse IgG was detected using a modification of a previously 
described technique (26). Briefly, microtiter plates were coated with 
KLH (10 /zg/ml) in  100 mM NaHCO3  (pH 9.6) overnight at 
4~  and blocked for 1 h at room temperature with PBS containing 
1% BSA and 1% goat serum. After overnight incubation of the 
indicated dilution of the mouse serum sample in the sample wells 
at 4~  the plates were extensively washed, and then alkaline phos- 
phatase-conjugated  goat  anti-mouse  IgG  or  alkaline  phospha- 
tase-conjugated goat anti-human IgG was incubated in the plates 
for 2 h at room temperature. The plates were washed, substrate 
solution (p-nitrophenyl phosphate; Sigma Chemical Co.) was added, 
and absorbance at 405 nm was  measured as described above. 
Characterization of  In Vitro  Responsiveness  of  Peripheral T Cells after 
Immunization with KLH.  Peripheral T cells were assessed for their 
ability to generate an antigen-specific response to KLH as described 
(27, 28). Mice were primed by injection of KLH (10/zg) emulsified 
in CFA into their hind footpads.  Draining lymph nodes were har- 
vested 9-21 d after priming, a single cell suspension  was obtained 
as described above, and mononuclear cells were isolated by cen- 
trifugation over a Ficoll-Hypaque gradient. Highly enriched T cell 
preparations were obtained by passing the lymph node mononuclear 
cells through a nylon wool column (27, 28). APC were obtained 
from each mouse by harvesting their peritoneal exudate cells, '~70% 
of which were macrophages, by peritoneal lavage with cold PBS 
(27).  Irradiated (4,000 red) peritoneal exudate cells (2.5  x  10  s 
cells/well) were cultured with the highly purified lymph node T 
cells (4  x  10  s cells/well) and the indicated concentration of KLH 
in flat-bottomed microtiter plates  for 5 d.  Cellular proliferation 
was assessed by determining the incorporation of [3H]thymidine 
added (1/zCi/well) during the last 24 h of culture. No significant 
cellular proliferation was detected in control wells to which irradi- 
ated peritoneal exudate cells alone were added. 
StatisticalAnalysis of the Data.  The student's t test for unpaired 
data was used for all statistical  comparisons made. 
Results 
Cytometric Analysis of the hu-thy,/liv Implants.  3 mo after 
implantation of hu-thy/liv tissue under the kidney capsules 
ofBNX (BNX-hu) and SCID (SCID-hu) mice, selected mice 
were killed for analysis. At necropsy the implanted tissue in 
both the BNX-hu and SCID-hu mice had increased from the 
size implanted (,,ol mm  3) to ~5  x  10 mm.  The histolog- 
ical appearance of the hu-thy/liv implants closely resembled 
those of normal human thymus with clear demarcation of 
cortical and medullary regions. The expression of CD4 and 
CD8 by human thymocytes present in the hu-thy/liv implants 
was  examined  by  two-color  flow  cytometry.  The  human 
thymus implanted in the SCID-hu (Fig. 1 A) and the BNX- 
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Figure  1.  Flow  cytometric  analysis of the hu-thy/liv implant in SC1D-hu 
mice and BNX-hu mice. Thymocytes from the hu-thy/liv implant from 
a SCID-hu (A and C) or a BNX-hu mouse (B and D) were analyzed by 
two-color flow cytometry for the expression of human CD4 and CD8 
(A and B) or for mouse CD4 and CD8 (C and D), as described  in Materials 
and Methods. Percentages  of cells in each quadrant are indicated. The im- 
munofluorescence  profiles shown reflect the profiles obtained from anal- 
ysis of three SCID-hu and three BNX-hu hu-thy/liv implants. 
823  Kollmann  et al. Figure 2.  Photomicrographs  of serial  sections of the 
BNX-hu hu-thy/liv graft immunoperoxidase stained 
for the detection of human CD45, mouse CD4, and 
mouse  CD8  expression. (A)  Antibodies  to human 
CD45 stained the majority of the cells in the graft. 
Several clusters of nonstaining  cells were distributed 
throughout  the  implant. The  nonstaining human 
CD45 clusters corresponded to cells that stained with 
(B) antibodies to mouse CD4 and (C) antibodies to 
mouse CDS.  High-power  views of the cell clusters 
using two Hassars corpuscles as landmarks in serial 
sections showed (D) human CD45 staining of cells 
in the upper half, and (E) mouse CD4 and (F) mouse 
CD8 staining of cells in the lower half. The photo- 
graphs shown are representative of three BNX-hu hu- 
thy/liv implants studied (A-C) 30 x ; (D-F) 300 x. 
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thymocytes. Over 85% of the human lymphocytes in the hu- 
thy/liv implants from the SCID-hu and BNX-hu mice were 
double positive for CD4 and CD8, and the remainder were 
single positive for either CD4 or CD8.  Thus, 3 mo after 
implantation  into BNX-hu and SCID-hu mice, phenotypic 
maturation of human T cells was continuing to occur in the 
hu-thy/liv implant comparable to differentiation of thymo- 
cytes in normal human thymus (29). However, whereas al- 
most all of the lymphocytes in the SCID-hu hu-thy/liv im- 
plant  were  positive  for  either  human  CD4  or  CD8,  a 
significant percentage of lymphocytes in the BNX-hu hu- 
thy/liv implant  were negative for these markers. To deter- 
mine whether mouse T cells were present in the BNX-hu 
hu-thy/liv implant and accounted for the population of cells 
that did not express human CD4 or CD8, we assessed the 
expression of mouse CD4 and CD8 by thymocytes in the 
hu-thy/liv implant. Whereas no mouse T cells were observed 
in the SCID-hu hu-thy/liv implant (Fig. 1 C), 9.2% of the 
cells detected in the BNX-hu implant (Fig. 2 D) were mouse 
T  cells that were either single positive for CD4 or CD8 
(2.2%), or double positive for CD4 and CD8 (7.0%). The 
relative percentages of the major murine thymocyte  subpopu- 
lations detected in the BNX-hu hu-thy/liv implant were com- 
parable to that which occurs in the normal mouse thymus (16). 
Immunohistochemical Assessment of the Thymic Implants.  The 
anatomical distribution of the mouse thymocytes in the hu- 
thy/liv implant was determined by immunohistochemical 
staining of serial sections of the hu-thy/liv implants for ex- 
pression of mouse CD4 and CD8. In addition,  to delineate 
the location of mouse thymocytes  relative to human thymo- 
cytes, serial sections of the hu-thy/liv implants were evalu- 
ated for the expression of the human leukocyte common an- 
tigen, CD45, which is present on human thymocytes at all 
stages of differentiation (30). Almost all of the cells present 
in the hu-thy/liv implant in SCID-hu mice expressed human 
CD45, and no thymocytes positive for mouse CD4 and CD8 
were observed (data not shown).  In contrast,  although the 
majority of ceUs present in the hu-thy/liv implant in BNX-hu 
mice were positive for human CD45, clusters of cells were 
observed in some thymic lobes that did not express human 
CD45 (Fig. 2 A), but rather expressed  both mouse CD4 (Fig. 
2 B) and mouse CD8 (Fig. 2 C). Examination of serial sec- 
tions of the BNX-hu hu-thy/liv implant under higher power 
demonstrates the reciprocal distribution of human cells ex- 
pressing CD45 (Fig. 2 D) and murine cells expressing CD4 
(Fig. 2 E) or CD8 (Fig. 2 F).  Taken together these results 
indicate that mouse thymocytes that were double  positive 
for CD4 and CD8 were localized in discrete regions of the 
human thymus. However, although most murine CD8 cells 
in the implant were confined to the human CD45-negative 
and murine CD4-positive  regions, low numbers of mouse 
CD4-positive cells were also found dispersed throughout the 
implant. Examination of expression of mouse Ia in the hu- 
thy/liv implants indicated that dendritic-appearing cells posi- 
tive for mouse Ia were scattered in the SCID-hu (Fig. 3 A) 
and BNX-hu (Fig. 3 B) implants. 
Reconstitution of the Murine Immune System in BNX-hu Mice. 
The effect of implantation of hu-thy/liv tissue on repopula- 
tion of the murine peripheral cellular immune system of the 
mice was examined by evaluating the mouse CD4- or CD8- 
positive lymphocyte population present in the peripheral  blood, 
spleen, and lymph nodes of nine BNX-hu mice. The BNX-hu 
mice displayed  a significant increase in CD4- or CD8-express- 
ing murine lymphocytes  in the peripheral blood, spleen, and 
lymph nodes (p <0.01) when compared with age-matched 
control BNX mice (Table 1). In contrast, the number of mouse 
CD4- or CD8-positive  lymphocytes in SCID-hu mice was 
not affected by the hu-thy/liv implant (data not shown). 
The function of the reconstituted peripheral  T  cells in 
BNX-hu mice was assessed  by investigating their responsive- 
ness to stimulation with ligands that interact with the TCR- 
CD3 complex, such as PHA, Con A, or antibodies directed 
to the CD3e component of the mouse TCR-CD3 complex 
(31). As shown in Fig. 4, the response of splenic T cells from 
BNX-hu mice to PHA stimulation was significantly greater 
than that of splenic T cells from BNX mice (p <0.001),  as 
was the response of splenic T cells from three BNX-hu mice 
(nos. 1, 2, and 4) to Con A (p <0.01). To further assess the 
function of T cells in the BNX-hu mice, splenocytes were 
stimulated with immobilized anti-mouse CD3e and a sur- 
rogate second signal, PMA (31). In contrast to splenocytes 
from BNX mice, which exhibited minimal response to stim- 
ulation with anti-mouse CD3e and PMA, splenocytes from 
BNX-hu mice proliferated vigorously in response to stimu- 
lation with anti-mouse CD3e and PMA (Table  2). Little cel- 
lular proliferation was observed in the absence  of  cellular stim- 
ulation or if the cells were stimulated with PMA alone. The 
degree of functional reconstitution of T  cell immunity in 
BNX-hu mice was further investigated  by assessing their ability 
to  mount  an  antigen-induced in  vitro  T  cell-dependent 
proliferative response after in vivo priming (24, 25). After 
immunization of  BNX-hu and BNX mice with KLH, a highly 
enriched T cell population was obtained from their draining 
lymph nodes and stimulated in culture with KLH. As shown 
in Fig.  5, in contrast  to T  cells from BNX mice that did 
not respond to KLH, T cells from BNX-hu mice displayed 
a significant proliferative  response to KLH in a dose-responsive 
manner. 
The effect that reconstitution of the T cell compartment 
of the BNX-hu mice had on mouse Ig production was as- 
sessed by determining the concentration of mouse IgG sub- 
classes in  serum from BNX-hu mice.  In contrast to  the 
markedly reduced levels of all IgG subclasses observed in sera 
from age-matched control BNX and preimplant BNX-hu 
mice, all mouse IgG subclasses  were detected at either normal 
or elevated levels in the postimplant BNX-hu mice (Table 
3).  The concentration of mouse IgG in the serum of the 
SCID-hu mice was not affected  by implantation of hu-thy/liv 
tissue. The B cell function of the BNX-hu mice was further 
evaluated by examining their capacity to mount an antigen- 
specific humoral immune response to KLH. After BNX and 
BNX-hu mice received two immunizations with KLH, the 
presence of mouse IgG directed to KLH was assessed. Whereas 
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immunoperoxidase- stained sections 
for the detection of mouse Ia expres- 
sion. Cells exin~sing mouse Ia were 
detected in the hu-thy/liv implant 
from the (,4) SCID-hu mouse and 
the (B) BNX-hu mouse. The elon- 
gated cell processes of the stained 
cells were suggestive  of dendritic 
type cells, x300. 
no IgG response directed to KLH was detected in the serum 
of BNX mice immunized with KLH, a significant  murine 
IgG  response  to  KLH was observed  in  KLH-immunized 
BNX-hu mice (Fig. 6). No human IgG antibodies  directed 
to KLH were detected. 
Detection of  Human T Cells  and lgG in SCID-hu and BNX-hu 
Mice.  Since  human T cells and IgG can be detected in the 
blood of SCID-hu mice (19), the degree  of reconstitution 
of BNX-hu mice with the human immune system was com- 
pared with that observed in SCID-hu mice. As shown in Table 
4,  although cells positive  for human  CD4 and  CD8 were 
detected in the peripheral blood of  both SCID-hu and BNX- 
hu mice, a significantly  higher percentage  of human CD4- 
positive cells was detected in SCID-hu than in BNX-hu mice 
0s <0.05). No human CD4- or CD8-positive cells were de- 
tected in the spleen or lymph nodes of BNX-hu mice. 6 wk 
after implantation,  the concentration of human IgG present 
in the serum of  BNX-hu and SCID-hu mice was determined 
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Mouse  CD4  CD8  CD4  CD8  CD4  CD8 
BNX  1.13  _+  0.19  0.53  +  0.15  3.12  _+  1.18  1.22  _+  0.67  4.55  _+  0.73  1.95  _+  0.62 
BNX-hu  17.33  _+  2.08  7.81  +  1.91  14.99  _+  1.57  5.54  _+  1.34  34.01  _+  3.15  8.98  _+  1.21 
C.B-17  28.5  _+  1.03  5.25  _+  1.43  24.50  _+ 0.75  9.00  _+  0.35  40.50  _+  3.05  25.50  _+  3.34 
Mononuclear cells obtained from the blood, lymph nodes, and spleen of either BNX mice (n  =  6), BNX-hu mice 3 mo after implantation (n  = 
9), or C.B-17 mice (n  =  4) were analyzed by flow cytometry. The mean percentage of cells within the lymphocyte gates expressing mouse CD4 
or CD8  of the analyzed mice  _+  SEM  is shown. 
Table  2.  Proliferative Responses of Splentocytes after Activation with Antibodies Directed against the CD3e Component 
of the Mouse TCR-CD3  Complex 
Mouse  Unstimulated  PMA  Anti-mouse  CD3e  +  PMA 
BNX  no.  1  131  +  22  307  _+  44  905  _+  204 
BNX  no.  2  151  _+  33  392  _+  51  519  _+  50 
BNX-hu  no.  1  139  _+  5  1079  _+  133  106,894  _+  3,055 
BNX-hu  no.  2  2,085  +  55  3,289  +  385  119,440  _+  7,230 
BNX-hu no.  3  381  +  59  1,471  _+  154  76,887  _+  1,255 
Splenocytes (2  x  10S/well) from the indicated mouse were either not stimulated,  stimulated with PMA (1 ng/ml), or stimulated with PMA (1 ng/ml) 
and immobilized antibody to mouse CD3e (2.5 /~g/well) for 3 d as described  in Materials and Methods.  Results are reported as cpm  +_  SEM  of 
triplicate wells. 
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Figure  4.  Proliferative  responses to mitogens. The response of spleen 
cells from the indicated mice to stimulation with either PHA (0.25/~g/well) 
or Con A (0.5/~g/well) determined as described in Materials and Methods. 
Results are reported as cpm  _+  SEM of quadruplicate wells. 
2000 
Table  1.  Flow Cytometric Analysis of Blood, Lymph Node, and Spleen of BNX, BNX-hu,  and C.B-17 Mice 
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Figure  5.  Response of T cells from KLH-immunized mice to stimula- 
tion with KLH. Highly enriched T cells (4  x  10  s calls/well) isolated from 
the lymph nodes of three immunized BNX mice and five immunized 
BNX-hu mice were cultured with irradiated  (4,000 tad) APC (2.5  x  10  s 
peritoneal exudate calls/well)  and the indicated concentration of KLH for 
5 d as described in Materials and Methods. Results from three immunized 
BNX mice and five immunized BNX-hu mice are shown as mean cpm 
_+  SEM  triplicate cultures of the studied mice. 
828  Murine Immune System  Reconstituted by Human Fetal Thymus Table  3.  Quantitation of Mouse IgG Subclass Antibodies in BNX and Pre- and Postiraplant BNX-hu and SCID-hu  Mice 
Mouse  IgG1  IgG2a  IgG2b  IgG3 
rag/ral 
BNX  0.20  _+  0  0  0  0 
BNX-hu  (preimplant)  0.23  _+  0.06  0  0  0 
BNX-hu  (postimplant)  22.32  _+  4.16  12.83  _+  3.27  2.02  +  0.33  1.50  _+  0.06 
SCID-hu  (preimplant)  0  0  0  0 
SCID-hu  (postimplant)  0.04  _+  0.04  0  0  0 
The concentrations  of mouse IgG1, IgG2a,  IgG2b, and IgG3 in the serum of SCID-hu mice before and 6 wk after hu-thy/liv implantation (n  = 
6),  BNX-hu mice before and 6 wk after  hu-thy/liv implantation (n  =  6),  and BNX mice (n  =  2) housed  together with the BNX-hu mice were 
measured  and  are shown as mean  _+  SEM. 
using an ELISA specific for human IgG. As shown in Fig. 
7, low quantities of human IgG were detected in the sera 
from both the SCID-hu and the BNX-hu mice. However, 
significantly more human IgG was present in SCID-hu than 
in BNX-hu mice (p <0.05). Taken together these results in- 
dicate  that although some degree of reconstitution of the 
human immune system was occurring in BNX-hu mice, sig- 
nificantly more reconstitution occurred in SCID-hu mice. 
Discussion 
In the present study, we investigated whether mouse thy- 
mocytes could differentiate in a human thymic environment. 
Although only a minority of the thymocytes present in the 
hu-thy/liv implant were murine, the relative percentage of 
murine thymocytes double positive for CD4 and CD8 (76%) 
was comparable to that present in the normal adult mouse 
thymus (80%) (16). Thus, human thymus may substitute for 
the congenitally absent mouse thymus in providing an envi- 
ronment for mouse thymocyte differentiation. After thymic 
implantation in  BNX  mice,  quantitative increases in the 
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Figure  6.  Detection of KLH-speciiic  mouse IgG by ELISA. Marine 
IgG antibodies directed to KLH in serum obtained from KLH-immunized 
BNX-hu (A) and BNX mice (e) (n  -  2) were assessed by ELISA as 
described in Materials and Methods. Values shown are the mean of specific 
absorbance at 405 nm of quadruplicate  determinations  for each reciprocal 
dilution of mouse serum assayed and were normalized for mouse IgG con- 
centration. 
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numbers of mouse T  cells present in the peripheral blood, 
spleen, and lymph nodes were observed. These peripheral T 
cells in the BNX-hu mice had the functional capacity to re- 
spond to stimulation with mitogens and antibodies directed 
against the CD3e component of the mouse TCR-CD3 com- 
plex.  In  addition, T  cells isolated  from lymph nodes of 
BNX-hu mice immunized with KLH displayed an antigen- 
specific proliferative response to KLH. It is unlikely that the 
response observed reflected the proliferation of human T cells, 
as no human T cells were detectable by flow cytometric anal- 
Table  4.  Percentage  of Huraan CD4- and CD8-expressing 
Leukocytes in the Peripheral Blood of SCID-hu  and BNX-hu  mice 
Mouse  Human  CD4  Human  CD8 
SCID  0  _+  0  0  _+  0 
SCID-hu  3.98  _+  0.24  0.10  _+  0.04 
BNX  0  _+  0  0  _+  0 
BNX-hu  0.17  _+  .05  0.08  _+  0.03 
PBL from SCID mice (n  =  2), BNX mice (n  =  2), SCID-hu (n  =  6), 
and BNX-hu (n  ~  6) were stained  for the expression of human CD4 
or CD8 and analyzed by flow cytometry as described in Materials  and 
Methods.  The mean  _+  SEM percent  positive  cells is shown. 
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Figure 7.  Measurement of ha- 
man  IgG  in  BNX-hu  and 
￿9  SCID-ha serum. The concentra- 
tions of human IgG present in the 
:  serum  of BNX-hu  (n  =  6)  or 
JL  SCID-hu mice (n = 6) 6 wk after 
reconstitution were determined by 
a human IgG-specific  ELISA as 
described in Materials and Meth- 
ods. The serum concentration  of 
human  IgG  for  each  mouse  is 
-  shown as well as the mean for the 
SCID-hu  group. ysis in the spleens or lymph nodes of the BNX-hu mice. 
Thymic transplantation also corrected the T cell-dependent 
B cell defect in BNX mice. This was evidenced by the nor- 
malization of serum IgG subclass levels in BNX-hu mice and 
the ability of KLH-immunized BNX-hu mice to mount an 
antigen-specific  antibody response to KLH. 
The absence of comparable reconstitution in age-matched 
BNX mice housed together with the BNX-hu mice for the 
entire period of the experiment indicated that the restoration 
of the murine immune system was due to the implanted tissue 
and not to environmental factors. As reported after transplan- 
tation of adult thymus into untreated SCID mice (32), we 
did not detect significant numbers of CD4- or CDS-positive 
mouse cells in the SCID-hu hu-thy/liv implant. 
The regional clustering of the double-positive murine T 
cells in the BNX-hu hu-thy/liv implant suggested that mouse 
pre-T cells from the bone marrow homed to the hu-thy/liv 
implant and subsequently differentiated.  It is unlikely that 
this reflects deposition of circulating double-positive T cells 
that had differentiated extrathymically, because while >75% 
of the mouse T cell population in the implant consisted of 
double-positive lymphocytes, no double-positive mouse T cells 
were detected in the peripheral blood, spleen, lymph nodes, 
or thymic rudiments of the BNX-hu mice.  The detection 
of TCR-~- mouse T cells in adult human thymic tissue en- 
grafted in anti-asialo GM-l-treated SCID mice led Barry et 
al. (32) to suggest that mouse pre-T cells could home to the 
human thymus. However,  since mouse T cells double posi- 
tive for CD4 and CD8 were not demonstrated in the thymic 
implant, the possibility that the mouse T cells present in the 
human  thymus  were  mediating  graft  rejection  and  not 
maturing in the thymic graft could not be excluded.  This 
contrasts  with  our  observation of mouse thymocytes at 
different stages of differentiation in the hu-thy/liv implant 
in BNX-hu mice. The mechanism by which mouse pre-T cells 
home to the human thymus is unknown, but it may be related 
to the ability of mouse thymocytes to bind to human thymic 
epithelial cells reported by Barry et al.  (32).  Colonization 
of the human thymus implanted into SCID-hu mice with 
mouse Ia + dendritic cells has been reported (19), and was 
observed by us in the SCID-hu and BNX-hu hu-thy/liv im- 
plants. An intriguing possibility is that the mouse dendritic 
cells that colonize the implant may play a role in the homing 
and maturation of the mouse T cells in the BNX-hu thymic 
implant. 
After implantation, the degree of peripheral reconstitution 
of the BNX-hu mice with CD4- or CD8-expressing mouse 
lymphocytes varied, Whereas the percentage of CD4 § lym- 
phocytes in BNX-hu mouse lymph nodes (34%) was com- 
parable to that of C.B-17 mouse lymph nodes (40.5%), the 
percentage of CD8 + cells in  the BNX-hu  mouse lymph 
nodes (8.9%) was lower than that of the C.B-17 mouse lymph 
node (25.5%). Lymph nodes of nude mice implanted with 
rat thymus exhibited preferential reconstitution of the mouse 
CD4-positive lymphocyte population compared with the 
mouse CDS-positive lymphocyte population, and this was 
felt to reflect an impairment in the positive selection of CD8- 
positive cells against  class I rat MHC molecules (33).  It is 
possible that the differential distribution of mouse CD4 and 
CD8 cells in BNX-hu mice may reflect the localization of 
T cell populations that underwent positive selection for self- 
MHC restriction extrathymically and then underwent fur- 
ther thymus-dependent  differentiation  and negative selection 
intrathymicaUy (34). 
The fraction of the human T cells and the concentration 
of human IgG detected in the peripheral blood of the BNX-hu 
mice was significantly less than that observed in the SCID-hu 
mice. Although maturation of human thymocytes in the hu- 
thy/liv graft was not affected by the reconstituted BNX-hu 
mouse immune system, peripheral engraftment of human lym- 
phocytes might have been inhibited. This may be either a 
result of the production of natural antibodies by the recon- 
stituted BNX-hu immune system that can inhibit engraft- 
ment of xenografts as reported for the rat--~mouse species 
combination (35), or may be the effect of other murine my- 
eloid cells (6). 
The presence of both human and mouse double- and single- 
positive thymocytes in the hu-thy/liv implant at relative per- 
centages comparable to normal human thymus (29) and normal 
murine thymus (16) >3 mo after implantation suggested that 
active thymic maturation of both lineages was occurring. This 
contrasts with rat thymic tissue implanted in nude mice, where, 
although the rat thymus became populated with large numbers 
of murine lymphocytes, few rat lymphoid cells were observed 
(36). The most likely explanation for this difference is that 
the human fetal liver coimplanted adjacent  to the thymus 
provided a source of human pre-T cells to undergo matura- 
tion in the hu-thy/liv implant. This is compatible with the 
recent observation of Namikawa et al.  (13) that long-term 
human T lymphopoiesis occurred much more frequently when 
hu-thy/liv were coimplanted in the same SCID-hu mice than 
when human thymus alone was implanted. Similarly, Frey 
et al. (12) demonstrated that mouse thymus implanted in SCID 
mice atrophied after 4-5 wk unless it was replenished with 
stem cells from cotransplanted normal mouse bone marrow 
stem cells. 
Examination of the function of human and mouse lym- 
phocytes that matured together in the thymus should prove 
useful in understanding the process of positive and negative 
selection in the thymic environment. In/iddition, matura- 
tion of murine T cells in human thymus may permit a unique 
strategy to evaluate the effects of T cell maturation in an HIV- 
infected thymic environment. Because murine cells are not 
susceptible  to HIV infection, the consequences  of HIV in- 
fection of human thymic cells on mouse T cell maturation 
can be studied independently of the influence of their infec- 
tion with HIV. The presentation of HIV antigens to murine 
T cells undergoing maturation in the thymus may result in 
the negative selection of T cells expressing antigen receptors 
that recognize HIV antigens.  This may have implications in 
understanding the effect  of congenital HIV  infection on 
maturation and clonal deletion of uninfected T cells in the 
thymus (37). 
BNX-hu mice with a reconstituted autologous immune 
830  Murine Immune System Reconstituted by Human  Fetal Thymus system that are tolerant to the continued presence of human 
T  cells may prove useful as a new model for the evaluation 
of vaccines for human-specific pathogens. Although the elicited 
immune response in the BNX-hu model is that of mouse 
origin and not of human origin, nevertheless,  the BNX-hu 
mice mounted a significant systemic murine IgG and T cell 
response after immunization with KLH (Figs. 5 and 6). Since 
human thymic implants in BNX-hu mice could be produc- 
tively infected with HIV, as described for SCID-hu mice (38), 
BNX-hu mice may be useful in the evaluation of the capacity 
of HIV vaccines to generate in vivo murine protective im- 
mune responses. After immunization with an HIV antigen, 
the ability of the resultant murine immune response to pro- 
tect the thymic implant from HIV infection could be assessed. 
Coimplantation of other human fetal tissue with the hu-thy/liv 
should also permit the use of this model for the investigation 
of vaccines directed against other human-specific pathogens. 
We thank C. Rapelje for assistance in the flow cytometry, A. Watford for assistance in animal care, and 
F. Lilly and J. Berman for critical reading of the manuscript. 
This work was supported by the National Institutes of Health (research grants AI-20671 and AI-27741). 
Address correspondence to Harris Goldstein, Forchheimer Building, Room 403, Albert Einstein College 
of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461. 
Received for publication 25June  1992 and in revised form  19 November  1992. 
~ql~rences 
1.  Dick, J.E. 1991. Immune-deficient mice as models of normal 
and leukemic human hematopoiesis. Cancer Cells. 3:39. 
2.  Sharabi, Y., I. Aksentijevich, T.M. Sundt III, D.H. Sachs, and 
M. Sykes. 1990. Specific  tolerance induction across a xenogeneic 
barrier: production of mixed rat/mouse lymphohematopoietic 
chimeras using nonlethal preparative regimen. J. Exp. Ailed. 
172:195. 
3.  Andriole, G.L., J.J. Mule, C.T. Hansen, W.M. Linehan, and 
S.A. Rosenberg. 1985. Evidence that lymphokine-activated 
killer cells and natural killer cells are distinct based on an anal- 
ysis of  congenitally  immunodeficient  mice.J. Immunol. 135:2911. 
4.  Kamal-Reid,  S., andJ.E. Dick. 1988. Engraftment of  immune- 
deficient mice with human hematopoietic stem cells. Science 
(Wash. DC).  242:1706. 
5.  Schuler, W., I.J. Weiler, A. Schuler, K.A. Phillips, N. Posen- 
berg, T.W. Mak, J.F. Kearney, K.P. Perry, and M.J. Bosma. 
1986. Rearrangement of antigen receptor genes is defective  in 
mice with severe combined deficiency. Cell. 46:963. 
6.  Bosma, M.J., and A.M. Carrol. 1991. The SCID mouse mu- 
tant: definition, characterization,  and potential uses. Annu. Rev. 
Immunol. 9:323. 
7.  Hong,  R.,  H.  Schulte-Wissermann, E.  Jarrett-Toth,  S.D. 
Horowitz, and D.D. Manning. 1979. Transplantation of cul- 
tured thymic fragments. II. Results in nude mice.J. Exp. Med. 
149:398. 
8.  Zinkemagel,  IL.M.,  A. Althage, and G. CaUahan. 1979. Thymic 
reconstitution  of nude F1 mice with one or both parental 
thymus grafts. J. Exl~ Med. 150:693. 
9.  Zinkernagel, K.M., A. Althage, E. Watel'field, B. Kind  re~l, 
R.M. Welsh, G. Callahan, and P. Pincetl. 1980. Restriction 
spedfidties, alloreactivity,  and allotolerance  expressed by T cells 
from nude mice reconstituted with H-2-compatible  or -incom- 
patible thymus grafts. J. Exl~ Med. 151:376. 
10. Lake,  J.P., M.E. Andrew, C.W. Pierce, and T.J. Braciale. 1980. 
Sendai virus-specific, H-2-restricted cytotoxic T lymphocyte 
responses of nude  mice grafted  with  allogeneic or  semi- 
allogeneic thymus glands. J. Exp. Med. 152:1805. 
11.  Manning, J.K., and K. Hong.  1984. Transplantation of cul- 
tured thymic fragments: results in nude mice. V. Reconstitu- 
tion with xenogeneic (rat) thymic tissue. Stand. J. Immunol. 
19:403. 
12.  Frey,  J.K., B. Ernst, C.D. Surh, andJ. Sprent. 1992. Thymus- 
grafted SCID mice show transient thymopoeisis and limited 
depletion of V~11 + T cells.  J. Exp. Med. 175:1067. 
13.  Namikawa, R., K.N. Weilbaecher, H. Kaneshima, EJ. Yee, 
andJ.M. McCune. 1990. Long-term hematopoiesis  in the SCID 
mouse. J. Exi~ Med. 172:1055. 
14.  Sprent, J., D. Lo, E.-K. Gao, and Y. Ron. 1988. T cell selec- 
tion in the thymus. Immunol. Rev. 101:73. 
15.  Schwartz, K.H.  1988. Acquisition of immunological self- 
tolerance. Cell. 57:1073. 
16.  Fowlkes, BJ., and D.M. Pardoll. 1989. Molecular and cellular 
events of T cell development. Adv. Immunol. 44:207. 
17.  Kollmann, T.IL., A. Kubinstein, W.D. Lyman, K. Soeiro, and 
H, Goldstein. 1991. Characterization of fetal IgG subclass an- 
tibodies directed against HIV-1. AIDS ges. Hum. Retroviruses. 
7:847. 
18.  Metcalf, D., K. Wakonig-Vaartaja,  and T.K. Bradle. 1965. The 
growth and repopulation of thymus grafts placed under the 
kidney capsule. Aust. J. Biol. Sci. 43:17. 
19.  McCune, ].M., K. Namikawa, H. Kaneshima, L.D. Shultz, 
M. Lieberman,  and I.L. Weissman. 1988. The SCID-hu mouse: 
murine model for the analysis of human  hematolymphoid 
differentiation and function. Science (Wash. DC). 241:1632. 
20.  Mishell, B.B., and S.M. Shiigi. 1980. Selected  Methods in Im- 
munology.  W.H. Freeman  and Company,  San Francisco. 24-25. 
21.  Goldstein, H., D. Koerholz, L. Chesky, X.-D. Fan, and J.L. 
Ambrus, Jr. 1990. Divergent activities of protein kinases in 
Ib6-induced differentiation of a human B cell line.J. Immunol. 
145:952. 
22.  Stein, P.L., H.-M. Lee, S. Rich, and P. Soriano. 1992. pp59~n 
mutant mice display differential signaling in thymocytes and 
peripheral T cells. Cell. 70:741. 
23.  Appelby,  M.W., J.A. Gross, M.P. Cooke, S.D. Levin, X. Qian, 
831  Kollmann  et al. and K.M. Perlmutter. 1992. Defective  T cell receptor signaling 
in mice lacking the thymic isoform of p59~.  Cell. 70:751. 
24.  Barth, W.F., C.L. McLaughlin, andJ.L. Fahey.  1965. The im- 
munoglobulins of mice. VI. Response to immunization.f Ira- 
raunol. 95:781. 
25.  Dixon, F.J., H. Jacot-Guillarmod, and P.J. McConahey. 1966. 
The antibody responses of rabbits and rats to hemocyanin,  f 
Immunol.  97:350. 
26.  Volkman, D.J., H.C.  Lane, and A.S. Fauci. 1981. Antigen- 
induced in vitro antibody production in humans: a model for 
B ceU activation and immunoregulation. Proa Natl. Acad. Sci. 
USA.  78:2528. 
27.  Rosenwasser, L.J., and A.S. Rosenthal. 1978. Adherent cell 
function in murine T lymphocyte antigen recognition. I. A 
macrophage-dependent  T cell proliferation  assay  in the mouse. 
J.  Immunol.  120:1991. 
28.  Corradin, G., H.M. Etlinger, and J.M. Chiller. 1977. Lym- 
phocyte specificity  to protein antigens. I. Characterization of 
the antigen-induced in vitro T  cell-dependent proliferative re- 
sponse with lymph node cells from primed mice.J. Immunol. 
119:1048. 
29.  Lanier, L.L.,  J.P. Allison, andJ.H, Phillips. 1986. Correlation 
of cell surface antigen expression on human thymocytes by 
multi-color flow cytometric analysis:  implications  for differen- 
tiation. J. Immunol.  137:2501. 
30.  Thomas, M.L. 1989. The leukocyte common antigen family. 
Annu.  R~.  Immunol.  7:339. 
31.  Weiss, A., J. Imboden, K. Hardy, I3. Manger, C. Terhorst, 
and J. Stobo. 1986. The role of the T3/antigen receptor corn- 
plex in T-cell activation. Annu.  R~.  Iraraunol. 4:593. 
32.  Barry,  T.S., D.M. Jones, C.B. Richter, and B.F. Haynes. 1991. 
Successful engraftment of human postnatal thymus in severe 
combined immune deficient (SCID) mice: differential  engraft- 
ment of thymic components with irradiation versus anti-asialo 
GM-1 immunosuppressive regimens, f  Exl~ Med.  173:167. 
33.  Iwasaki, A., Y. Yoshikai, M. Sakumoto, K. Himeno, H. Yuuki, 
M. Kumamoto, K. Sueishi, and K. Nomoto. 1990. Sequential 
appearance of host-derived T ceU subsets during differentia- 
tion in nude mice grafted with fetal thymus..].  Iramunol. 145:28. 
34.  Speiser,  D.E., U. Stubi, and R. Zinkernagd. 1990. Extrathymic 
positive selection of cxB T-cell precursors in nude mice. Nature 
(Lond.). 355:170. 
35.  Aksentijevich, I., D.H. Sachs, and M. Sykes. 1991. Natural 
antibodies can inhibit bone marrow engraftment in the rat-~ 
mouse species combination. J. Immunol.  147:4140. 
36.  Taguchi, O., T. Takahashi, M. Seto, R. Namikawa, M. Mat- 
suyama, and Y. Nishizuka. 1986. Development of multiple 
organ-localized  autoimmune diseases in nude mice after recon- 
stitution of T cell function by rat fetal thymus graft. J. Exp. 
Med.  164:60. 
37.  Papiernik,  M., Y. Brossard, N. Mulliez,  J. Roume, C. Brechot, 
F. Barin, A. Goudeau, J.F. Bach, C. Griscelli, R. Henrion, 
and R. Vazeux. 1992. Thymic abnormalities  in fetuses  aborted 
from  human  immunodeficiency virus type  1  seropositive 
women. Pediatrics. 89:297. 
38.  Namikawa, R., H. Kaneshima,  M. Lieberman,  I.L. Weissman, 
and J.M. McCune. 1988. Infection of the SCID-hu mouse by 
HIV-1. Science (Wash. DC).  242:1684. 
832  Murine  Immune System Reconstituted  by Human Fetal Thymus 